ArticleAnnals of medicine and surgery (2012)2026
Diagnosis, treatment management, and challenges in neurofibromatosis type 1: a case report with mixed features.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Circulating Tumor DNA in Neurofibromatosis Type 1: Translating Molecular Discovery into Clinical Surveillance.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Neurofibromatosis type 1 (NF1) is a prevalent genetic disorder; however, the incidence of plexiform neurofibromas remains relatively low. This article presents a case of mixed-type NF1 with plexiform neurofibroma. Case Presentation: Following domestic and international expert consensus, a multidisciplinary team conducted a comprehensive evaluation and formulated an individualized treatment plan. Although the diagnosis of NF1 was confirmed, the precise origin of the massive superficial mass in the child remains uncertain. Clinical Discussion: This study provides a comprehensive exploration of the clinical manifestations and theoretical underpinnings that facilitate the precise diagnosis, treatment, and long-term management of patients with NF1. Conclusion: In conclusion, the clinical management of pediatric NF1 patients is complex as therapeutic interventions are not for all. Due to heterogeneous manifestations and variable disease trajectories, there is no standardized treatment algorithm. Integrating molecular diagnostics, targeted therapies, and multidisciplinary care is crucial for personalized and effective long - term management of those with this genetic disorder.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.